nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Model for Evaluating Total Costs of Care and Cost Savings of Specialty Condition-Based Care for Hip and Knee Osteoarthritis in an Integrated Practice Unit
|
Jayakumar, Prakash |
|
|
26 |
9 |
p. 1363-1371 |
artikel |
2 |
A New Type 2 Diabetes Microsimulation Model to Estimate Long-Term Health Outcomes, Costs, and Cost-Effectiveness
|
Hoerger, Thomas J. |
|
|
26 |
9 |
p. 1372-1380 |
artikel |
3 |
A Rapid Review on the Value of Biobanks Containing Genetic Information
|
Rodriguez Llorian, Elisabet |
|
|
26 |
9 |
p. 1286-1295 |
artikel |
4 |
Balancing Data Privacy With Access to Health Services and Research: Facilitating Confidential Information Sharing in US Multisystem Collaborations
|
Worobiec, Michele |
|
|
26 |
9 |
p. 1325-1328 |
artikel |
5 |
Copyright/Subscription
|
|
|
|
26 |
9 |
p. v |
artikel |
6 |
Data Privacy and Health: How Do We Achieve the Right Balance?
|
Mullins, C. Daniel |
|
|
26 |
9 |
p. 1283-1285 |
artikel |
7 |
Does EQ-5D Tell the Whole Story? Statistical Methods for Comparing the Thematic Coverage of Clinical and Generic Outcome Measures, With Application to Breast Cancer
|
Hernández Alava, Mónica |
|
|
26 |
9 |
p. 1398-1404 |
artikel |
8 |
Editorial Board
|
|
|
|
26 |
9 |
p. vi |
artikel |
9 |
Evaluating the Value for Money of Precision Medicine from Early Cycle to Market Access: A Comprehensive Review of Approaches and Challenges
|
Chen, Wenjia |
|
|
26 |
9 |
p. 1425-1434 |
artikel |
10 |
Evaluation of Diversity of Clinical Trials Informing Health Technology Assessments in the United States: A 5-Year Analysis of Institute for Clinical and Economic Review Assessments
|
Agboola, Foluso |
|
|
26 |
9 |
p. 1345-1352 |
artikel |
11 |
Impacts of Chronic Obstructive Pulmonary Disease Care Pathway on Healthcare Utilization and Costs: A Matched Multiple Control Cohort Study in Saskatchewan, Canada
|
Kuwornu, John Paul |
|
|
26 |
9 |
p. 1334-1344 |
artikel |
12 |
Incorporating Added Therapeutic Benefit and Domestic Reference Pricing Into Medicare Payment for Expensive Part B Drugs
|
Anderson, Kelly E. |
|
|
26 |
9 |
p. 1381-1388 |
artikel |
13 |
Incorporating Prior Beliefs Into Meta-Analyses of Health-State Utility Values Using the Bayesian Power Prior
|
Hatswell, Anthony J. |
|
|
26 |
9 |
p. 1389-1397 |
artikel |
14 |
Mothers’ Views on the Storage and Usage of Their Children’s Biological Material Under the Danish Biobanking Model: A Narrative Approach Using Epistemic Injustice
|
Karlsson, Anne Wettergren |
|
|
26 |
9 |
p. 1308-1313 |
artikel |
15 |
Personal Location as Health-Related Data: Public Knowledge, Public Concern, and Personal Action
|
Rozier, Michael |
|
|
26 |
9 |
p. 1314-1320 |
artikel |
16 |
Reimagining Patient Data Access for Researchers
|
Parente, Stephen T. |
|
|
26 |
9 |
p. 1329-1333 |
artikel |
17 |
Streamlining Global and Local Data on HIV: Underscoring Role of Institutions and Ethics in Improving Quality of HIV Research
|
Mostert, Cyprian M. |
|
|
26 |
9 |
p. 1296-1300 |
artikel |
18 |
Table of Contents
|
|
|
|
26 |
9 |
p. i-iv |
artikel |
19 |
The Societal Impact of Inclisiran in England: Evidence From a Population Health Approach
|
Ostwald, Dennis A. |
|
|
26 |
9 |
p. 1353-1362 |
artikel |
20 |
Use of Big Data and Ethical Issues for Populations With Substance Use Disorder
|
Evans, Elizabeth A. |
|
|
26 |
9 |
p. 1321-1324 |
artikel |
21 |
US Residents’ Preferences for Sharing of Electronic Health Record and Genetic Information: A Discrete Choice Experiment
|
Wagner, Abram L. |
|
|
26 |
9 |
p. 1301-1307 |
artikel |
22 |
“What’s Sex and Gender Got to Do With It?” A Scoping Review of Sex- and Gender-Based Analysis in Pharmacoepidemiologic Studies of Medication Adherence
|
Rebić, Nevena |
|
|
26 |
9 |
p. 1413-1424 |
artikel |
23 |
Whose Time Trade-Off Should Be Used? Anchoring Discrete Choice Experiment Latent Utilities in Health State Valuation
|
Xie, Shitong |
|
|
26 |
9 |
p. 1405-1412 |
artikel |